Submit Deal

Submit Deal

Cover Image MRL VENTURES FUND

MRL VENTURES FUND

MRL VENTURES FUND

Summary

MRL Ventures is Merck’s independent early-stage therapeutics venture capital fund.

Deals Overview

Total Deals11

Valued Deals11

Total Value£ 796 M

Avg. Deal Size£ 72 M

Market Context

Parent Company

MERCK & CO

56 transactions

Sort

31 Mar 2021|United States|Biotechnology

Target: ENTRADA THERAPEUTICS INC

Bidder: WELLINGTON MANAGEMENT

16 Service Providers

2 Target | 14 Bidder

29 Dealmakers

5 Target | 25 Bidder

£ 84 M

Value

24 Feb 2021|United States|Biotechnology

Target: XILIO THERAPEUTICS

Bidder: RIVERVEST VENTURE PARTNERS

3 Service Providers

1 Target | 2 Bidder

3 Dealmakers

1 Target | 2 Bidder

£ 64 M

Value

29 Nov 2021|United States|Biotechnology

Target: HOTSPOT THERAPEUTICS

Bidder: SOFINNOVA PARTNERS

10 Service Providers

2 Target | 8 Bidder

11 Dealmakers

3 Target | 8 Bidder

£ 74 M

Value

06 Jan 2022|United States|Biotechnology

Target: AMBAGON THERAPEUTICS

Bidder: NEXTECH INVEST

4 Service Providers

3 Target | 1 Bidder

5 Dealmakers

4 Target | 1 Bidder

£ 62 M

Value

22 Feb 2022|United States|Biotechnology

Target: EYEBIOTECH

Bidder: SAMSARA BIOCAPITAL

6 Service Providers

3 Target | 3 Bidder

12 Dealmakers

8 Target | 4 Bidder

£ 47 M

Value

26 Oct 2021|United States|Biotechnology

Target: MOZART THERAPEUTICS

Bidder: LEAPS BY BAYER

9 Service Providers

2 Target | 7 Bidder

9 Dealmakers

2 Target | 7 Bidder

£ 43 M

Value

08 Sep 2022|United States|Health Care Services

Target: PHOTYS THERAPEUTICS

Bidder: ELI LILLY AND COMPANY

4 Service Providers

2 Target | 2 Bidder

8 Dealmakers

4 Target | 4 Bidder

£ 65 M

Value

16 May 2023|United States|Biotechnology

Target: RAY THERAPEUTICS

Bidder: PLATANUS

8 Service Providers

2 Target | 6 Bidder

9 Dealmakers

2 Target | 7 Bidder

£ 80 M

Value

27 Apr 2023|United States|Biotechnology

Target: THERINI BIO

Bidder: DEMENTIA DISCOVERY

5 Service Providers

3 Target | 2 Bidder

4 Dealmakers

2 Target | 2 Bidder

£ 28 M

Value

13 Nov 2023|Netherlands|Biotechnology

Target: VECTORY

Bidder: MERCK & CO

6 Service Providers

2 Target | 4 Bidder

10 Dealmakers

5 Target | 5 Bidder

£ 112 M

Value

30 Sep 2024|United States|Biotechnology

Target: AKTIS ONCOLOGY

Bidder: T. ROWE PRICE GROUP INC

10 Service Providers

2 Target | 8 Bidder

18 Dealmakers

3 Target | 15 Bidder

£ 130 M

Value

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

Privacy Policy Terms of Service Contact Us Cookie Preferences

All rights reserved. Copyright © 2025 Datasite